Literature DB >> 31327102

Does nociception monitor-guided anesthesia affect opioid consumption? A systematic review of randomized controlled trials.

Fleur S Meijer1, Marieke Niesters1, Monique van Velzen1, Chris H Martini1, Erik Olofsen1, Ruth Edry2, Daniel I Sessler3, Eveline L A van Dorp1, Albert Dahan1, Martijn Boon4.   

Abstract

Monitors that estimate nociception during anesthesia may be used to guide opioid and other analgesics administration to optimize anesthesia care and possibly outcome. We reviewed the literature to evaluate current evidence of the effect of nociception-guided management over standard anesthesia practice during surgery. A systematic review of the literature on the effect of nociception monitoring on anesthesia practice was conducted. Reports were eligible if they compared nociception-guided anesthesia to standard practice during surgery. Primary endpoint of this review is intraoperative opioid consumption. Secondary endpoints included hemodynamic control, postoperative pain and pain treatment. We identified 12 randomized controlled trials that compared one of five different nociception monitoring techniques to standard anesthesia care. Most studies were single center studies of small sample size. Six studies reported intraoperative opioid consumption as primary outcome. There was considerable variability with respect to surgical procedure and anesthesia technique. For nociception monitors that were investigated by more than one study, analysis of the pooled data was performed. The surgical plethysmographic index was the only monitor for which an intra operative opioid sparing effect was found. For the other monitors, either no effect was detected, or pooled analysis could not be performed due to paucity of study data. On secondary outcomes, no consistent effect of nociception-guided anesthesia could be established. Although some nociception monitors show promising results, no definitive conclusions regarding the effect of nociception monitoring on intraoperative opioid consumption or other anesthesia related outcome can be drawn.Clinical trial number PROSPERO ID 102913.

Entities:  

Keywords:  Nociception monitoring; Opioid consumption; Systematic review

Year:  2019        PMID: 31327102     DOI: 10.1007/s10877-019-00362-4

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  6 in total

1.  Analgesia Nociception Index (ANI) and ephedrine: a dangerous liasion.

Authors:  Rita Graça; Francisco A Lobo
Journal:  J Clin Monit Comput       Date:  2021-03-17       Impact factor: 2.502

2.  Usefulness of ANI (analgesia nociception index) monitoring for outpatient saphenectomy surgery outcomes: an observational study.

Authors:  Adolfo Ramos-Luengo; Adela Gardeta Pallarés; Fernando Asensio Merino
Journal:  J Clin Monit Comput       Date:  2020-02-28       Impact factor: 2.502

Review 3.  Chronic post-surgical pain - update on incidence, risk factors and preventive treatment options.

Authors:  D C Rosenberger; E M Pogatzki-Zahn
Journal:  BJA Educ       Date:  2022-02-24

4.  Pupillometry pain index decreases intraoperative sufentanyl administration in cardiac surgery: a prospective randomized study.

Authors:  Vivien Berthoud; Maxime Nguyen; Anouck Appriou; Omar Ellouze; Mohamed Radhouani; Tiberiu Constandache; Sandrine Grosjean; Bastien Durand; Isabelle Gounot; Pierre-Alain Bahr; Audrey Martin; Nicolas Nowobilski; Belaid Bouhemad; Pierre-Grégoire Guinot
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

5.  Reduced postoperative pain in patients receiving nociception monitor guided analgesia during elective major abdominal surgery: a randomized, controlled trial.

Authors:  Rivka Fuica; Carlos Krochek; Rachel Weissbrod; Dimitri Greenman; Andres Freundlich; Yaacov Gozal
Journal:  J Clin Monit Comput       Date:  2022-08-17       Impact factor: 1.977

6.  Analgesia Nociception Index-Guided Remifentanil versus Standard Care during Propofol Anesthesia: A Randomized Controlled Trial.

Authors:  Nada Sabourdin; Julien Burey; Sophie Tuffet; Anne Thomin; Alexandra Rousseau; Mossab Al-Hawari; Clementine Taconet; Nicolas Louvet; Isabelle Constant
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.